Chemung Financial (CMHG) Q4 2024 earnings summary

Executive summary

• Net income for 2024 was $23.7 million, down 5.3% from $25.0 million in 2023, with EPS of $4.96 versus $5.28 prior year.

• Return on average equity declined to 11.53% from 14.11%, and return on average assets fell to 0.86% from 0.94%.

• Total assets grew 2.4% to $2.78 billion, while loans increased 5.0% to $2.07 billion and deposits decreased 1.3% to $2.40 billion.

• Commercial real estate lending remains the largest loan segment, with notable growth in the Capital and Western NY regions.

• Wealth management assets under administration totaled $2.21 billion at year-end, with fee income up 10.6% year-over-year.

Financial highlights

• Net interest income decreased 0.5% to $74.1 million, as higher interest expense offset loan growth and higher yields.

• Non-interest income fell 5.4% to $23.2 million, mainly due to a $2.4 million one-time employee retention tax credit in 2023.

• Non-interest expense rose 4.7% to $67.3 million, driven by higher compensation, marketing, and data processing costs.

• Provision for credit losses was a $46,000 credit, compared to a $3.3 million provision in 2023, reflecting updated CECL model loss drivers.

• Efficiency ratio (adjusted) increased to 68.89% from 66.20%, reflecting higher expenses relative to revenue.

Outlook and guidance

• Management targets capital ratios above regulatory minimums and expects to continue internal capital generation and dividend payments.

• The company plans further branch expansion in Western NY and continued focus on commercial lending and wealth management growth.

• Interest rate risk remains a key focus, with ALCO monitoring and scenario analysis indicating all exposures within policy limits.